Clinical Utility of Epstein-Barr Virus Viral Load Monitoring and Risk Factors for Posttransplant Lymphoproliferative Disorders After Kidney Transplantation: A Single-Center, 10-Year Observational Cohort Study - Wikidata - wikimedia - TriplyDB

Clinical Utility of Epstein-Barr Virus Viral Load Monitoring and Risk Factors for Posttransplant Lymphoproliferative Disorders After Kidney Transplantation: A Single-Center, 10-Year Observational Cohort Study

Clinical Utility of Epstein-Barr Virus Viral Load Monitoring and Risk Factors for Posttransplant Lymphoproliferative Disorders After Kidney Transplantation: A Single-Center, 10-Year Observational Cohort Study

http://www.wikidata.org/entity/Q33874038

about

Clinical Utility of Epstein-Barr Virus Viral Load Monitoring and Risk Factors for Posttransplant Lymphoproliferative Disorders After Kidney Transplantation: A Single-Center, 10-Year Observational Cohort Study

http://www.wikidata.org/entity/Q33874038

description

2017 nî lūn-bûn

@nan

2017 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Clinical Utility of Epstein-Ba ...... ear Observational Cohort Study

@ast

Clinical Utility of Epstein-Ba ...... ear Observational Cohort Study

@en

type

label

Clinical Utility of Epstein-Ba ...... ear Observational Cohort Study

@ast

Clinical Utility of Epstein-Ba ...... ear Observational Cohort Study

@en

prefLabel

Clinical Utility of Epstein-Ba ...... ear Observational Cohort Study

@ast

Clinical Utility of Epstein-Ba ...... ear Observational Cohort Study

@en

P1433

Q33874038-0C3D3EB2-7B13-4349-9B8F-2E51C0B01756

P1476

Q33874038-D2F87C7F-397D-4DFA-B891-043717C7ED0A

P2093

Q33874038-1C722210-0A05-4E73-9027-23A363E73DCD

Q33874038-3254B5DA-97CF-44EE-9ED0-7BDC11DA6470

Q33874038-3E76EF6B-B53E-4B42-B772-F742B1987255

Q33874038-440BCB2F-7C67-4B6E-9E61-2507A721FFCC

Q33874038-4EF631AC-8090-4D7B-BD19-A5B70FFA901A

Q33874038-5C8A8484-516F-49AA-9A3F-70DE7B2210DC

Q33874038-81F13D78-FF19-4B99-8B31-AED26C1CEF94

Q33874038-861A8F6E-956E-4C2D-A4E2-0FB56E90EA37

Q33874038-9C581D2C-96D9-4971-A43E-D82EC55E2049

Q33874038-AABEBDD3-1257-42EC-9C86-BF36F33037DD

P2860

Q33874038-008373E7-B559-4C30-80D9-7939ACE8FB6E

Q33874038-1D9187AF-A144-49A0-8CFF-8CE8B83FCD7B

Q33874038-295A2F77-0EE4-4621-9C4B-2B7A0974F6E3

Q33874038-300A242C-3CA6-412A-B403-6F263906CF51

Q33874038-32007A0F-6AB3-403E-A5F3-136C9D28BE95

Q33874038-35E378AE-029C-40F8-B199-4160280C2F2D

Q33874038-3BD0C466-39A3-44F7-97D1-9BA1BB1F78A8

Q33874038-3F3688AB-E39A-49F5-AE01-F2FABF4D83D2

Q33874038-4958F985-71F6-4803-811A-E82EBD6F1B21

Q33874038-4F8922AA-0CBE-459A-A632-DE1E2AC979DC

P304

Q33874038-7881D0AC-0084-4B95-8C93-E900E0F2BE21

P31

Q33874038-D372B6CA-4330-46B2-9AC4-22F8A04D29D2

P356

Q33874038-38A9B1E3-5E1E-48EB-942B-1302FBB37959

P407

Q33874038-2D7BBAC6-908B-459B-8108-DACA6EC8F5B1

P433

Q33874038-8E735E68-4A8C-4312-BFAE-D274C855EDBE

P478

Q33874038-ACEC9370-6227-4C5D-BB68-DC511DAA445B

P50

Q33874038-AE3CE428-6F36-4B9F-9C9B-F9C7183EA935

Q33874038-B7E79159-9D39-4F8F-AC0A-CB1EA49F9BDF

Q33874038-DBC3D6DF-BB04-4A4E-ADD9-E13B0A204B5E

P577

Q33874038-2E46F66D-21D6-47C9-9EBC-80B0FDD304B9

P698

Q33874038-785655D6-9EE7-4FAD-AB57-E723F9189310

P921

Q33874038-0BB4A588-D10C-46F4-A1CC-8B659B494760

P932

Q33874038-BCE40EAF-A045-49D1-BB8C-4352B6F383BB

P356

TXD.0000000000000703

P1433

Transplantation direct

P1476

Clinical Utility of Epstein-Ba ...... ear Observational Cohort Study

@en

P2093

Antonella Santoro

http://www.w3.org/2001/XMLSchema#string

Cristina Mussini

http://www.w3.org/2001/XMLSchema#string

Francesca Facchini

http://www.w3.org/2001/XMLSchema#string

Gaetano Alfano

http://www.w3.org/2001/XMLSchema#string

Giovanni Guaraldi

http://www.w3.org/2001/XMLSchema#string

Inge C Gyssens

http://www.w3.org/2001/XMLSchema#string

Jessica Plessi

http://www.w3.org/2001/XMLSchema#string

Leonardo Potenza

http://www.w3.org/2001/XMLSchema#string

Margherita Digaetano

http://www.w3.org/2001/XMLSchema#string

Mario Luppi

http://www.w3.org/2001/XMLSchema#string

P2860

mTOR regulates memory CD8 T-cell differentiation

Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials.

Epstein-Barr virus infection.

Associations between EBV serostatus and organ transplant type in PTLD risk: an analysis of the SRTR National Registry Data in the United States.

Identifying the patient at risk for post-transplant lymphoproliferative disorder.

Epstein-Barr virus load monitoring: its role in the prevention and management of post-transplant lymphoproliferative disease.

Rapamycin inhibits the interleukin 10 signal transduction pathway and the growth of Epstein Barr virus B-cell lymphomas.

Lymphomas differ in their dependence on Epstein-Barr virus

The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications

Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States

P304

e182

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/TXD.0000000000000703

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Gianni Cappelli

Francesco Fontana

Erica Franceschini

P577

2017-06-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28706985

http://www.w3.org/2001/XMLSchema#string

P921

P932

5498023

http://www.w3.org/2001/XMLSchema#string